Showing 1 - 10 of 7,545
Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …
Persistent link: https://www.econbiz.de/10014136820
and stimulating innovation in the biotechnology sector, some policy levers narrow down the patent potential for …
Persistent link: https://www.econbiz.de/10014188440
Although economic literature has recently started to concentrate on the design, the scope and the regulations of main public programmes of Long-Term-Care in Europe, no analysis have, so far, compared different systems in terms of their degree of inclusiveness with respect to vulnerable elderly's...
Persistent link: https://www.econbiz.de/10013039883
Persistent link: https://www.econbiz.de/10008649926
Persistent link: https://www.econbiz.de/10001029953
Persistent link: https://www.econbiz.de/10003569442
Persistent link: https://www.econbiz.de/10009579289
Persistent link: https://www.econbiz.de/10001783803
pt. 1. Blurred boundaries : drug research and production in Britain and France before World War Two -- pt. 2. Collaborative networks in war and peace -- pt. 3. Continuity and change in medical science and industry after World War Two.
Persistent link: https://www.econbiz.de/10014499595
Ascertaining whether patents encourage invention necessitates understanding the incentives inventors respond to. The British patent system prior to its reform in 1852 was cumbersome and expensive. Whether it facilitated or delayed the Industrial Revolution is hotly debated. This paper's...
Persistent link: https://www.econbiz.de/10011904938